# A Study to Evaluate LY01011 and Xgeva® in Healthy Adults

> **NCT04198636** · PHASE1 · UNKNOWN · sponsor: **Luye Pharma Group Ltd.** · enrollment: 168 (estimated)

## Conditions studied

- Healthy Adults

## Interventions

- **DRUG:** LY01011
- **DRUG:** Xgeva 120 MG in 1.7 ML Injection

## Key facts

- **NCT ID:** NCT04198636
- **Lead sponsor:** Luye Pharma Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-16
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-06-30
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2019-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04198636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04198636, "A Study to Evaluate LY01011 and Xgeva® in Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04198636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*